Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : EntreMed (ENMD) -- Ignore unavailable to you. Want to Upgrade?

To: Vincent Vega who wrote (1667)	2/12/1999 8:18:00 AM
From: Sol W.	Respond to of 2135

IBD Front Page: 8. EntreMed's Cancer Drug Heads To Human Trials Date: 2/12/99 Scientists at the National Cancer Institute managed to duplicate a Harvard doctor's success with an experimental cancer treatment, and they plan to begin human testing by the fall. The proteins involved in the treatment are being developed by EntreMed. This week, Bristol-Myers Squibb ended a venture with EntreMed to develop one of the proteins. The natural proteins have been shown to starve tumors in lab mice and make the tumors fall dormant or disappear.